Hindustan Bio Sciences Ltd.
Hind Bio Science
₹ 0.00
0.00 (0.00)%
NSE
BSE
Healthcare
Small-cap - With a market cap of ₹9.29 Cr.
| EX-Date | Purpose |
|---|---|
| 22 04 2021 | Audited Results |
| 18 06 2021 | General Purpose |
| 06 08 2021 | Quarterly Results |
| 29 10 2021 | Quarterly Results |
| 04 02 2022 | Quarterly Results |
| 27 05 2022 | Audited Results |
| 29 07 2022 | Quarterly Results |
| 31 10 2022 | Quarterly Results |
| 31 01 2023 | Quarterly Results |
| 30 05 2023 | Quarterly Results |
| 31 07 2023 | Quarterly Results |
| 31 10 2023 | Quarterly Results |
| 04 12 2023 | Inter alia, for considering the notice of EGM intended for regularization of additional directors and approval of appointment of CFO of the company |
| 31 01 2024 | Quarterly Results |
| 30 10 2024 | Quarterly Results |
| 30 01 2025 | Quarterly Results |
| 23 04 2025 | Inter alia, to consider and approve the appointment of Company Secretary and Compliance Officer of the Company. |
| 30 05 2025 | Audited Results |
| 31 07 2025 | Quarterly Results |
| 31 10 2025 | Quarterly Results |
| 31 01 2026 | Quarterly Results |
No News data available
